Needham & Company Reiterates a 'Buy' on Photronics (PLAB); Success in High-End Should Continue to Drive Growth
Get Alerts PLAB Hot Sheet
Price: $27.76 --0%
Rating Summary:
2 Buy, 3 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 1
Rating Summary:
2 Buy, 3 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 1
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on Photronics (NASDAQ: PLAB), raises PT from $11 to $13.
Needham analyst says, 'We reiterate our rating on PLAB after a strong F2Q11 (Apr) report. We believe the record quarter with strong growth of highend sales confirms that PLAB is gaining share with leading-edge customers. As PLAB grows its top line, we see increased operating leverage in the financial model, driving higher earnings. Despite yesterday’s rally, PLAB looks undervalued at a CY12 P/E of just 9X. Based on strong EPS growth, we raise our PT...We raise our FY11 EPS estimate to $0.83 and FY12 to $0.90. Our new PT $13 is based on 13X our CY12 EPS of $1.00."
For more ratings news on Photronics click here and for the rating history of Photronics click here.
Shares of Photronics closed at $8.96 yesterday.
Needham analyst says, 'We reiterate our rating on PLAB after a strong F2Q11 (Apr) report. We believe the record quarter with strong growth of highend sales confirms that PLAB is gaining share with leading-edge customers. As PLAB grows its top line, we see increased operating leverage in the financial model, driving higher earnings. Despite yesterday’s rally, PLAB looks undervalued at a CY12 P/E of just 9X. Based on strong EPS growth, we raise our PT...We raise our FY11 EPS estimate to $0.83 and FY12 to $0.90. Our new PT $13 is based on 13X our CY12 EPS of $1.00."
For more ratings news on Photronics click here and for the rating history of Photronics click here.
Shares of Photronics closed at $8.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- ResMed (RMD) PT Raised to $236 at Needham
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & Company, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!